Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroencephalography | 38 | 2022 | 707 | 3.250 |
Why?
|
| Brain Mapping | 21 | 2020 | 548 | 2.210 |
Why?
|
| Epilepsy | 17 | 2019 | 395 | 1.810 |
Why?
|
| Visual Prosthesis | 3 | 2023 | 5 | 1.800 |
Why?
|
| Cerebral Cortex | 12 | 2020 | 584 | 1.750 |
Why?
|
| Visual Cortex | 8 | 2022 | 251 | 1.730 |
Why?
|
| Epilepsy, Temporal Lobe | 9 | 2022 | 122 | 1.290 |
Why?
|
| Electrodes, Implanted | 11 | 2023 | 171 | 1.150 |
Why?
|
| Evoked Potentials, Visual | 13 | 2019 | 87 | 1.030 |
Why?
|
| Language | 2 | 2020 | 151 | 0.970 |
Why?
|
| Nerve Net | 4 | 2020 | 366 | 0.950 |
Why?
|
| Brain | 17 | 2022 | 2216 | 0.890 |
Why?
|
| Evoked Potentials, Somatosensory | 9 | 2010 | 32 | 0.690 |
Why?
|
| Electrocorticography | 5 | 2020 | 37 | 0.590 |
Why?
|
| National Socialism | 1 | 2016 | 2 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2020 | 3352 | 0.570 |
Why?
|
| Visual Perception | 9 | 2022 | 319 | 0.530 |
Why?
|
| Neurology | 1 | 2016 | 70 | 0.530 |
Why?
|
| Auditory Cortex | 3 | 2022 | 58 | 0.530 |
Why?
|
| Speech Perception | 2 | 2021 | 71 | 0.510 |
Why?
|
| Electric Stimulation | 6 | 2023 | 347 | 0.510 |
Why?
|
| Temporal Lobe | 5 | 2022 | 172 | 0.510 |
Why?
|
| Occipital Lobe | 4 | 2023 | 24 | 0.460 |
Why?
|
| Phosphenes | 3 | 2021 | 5 | 0.450 |
Why?
|
| Pattern Recognition, Visual | 4 | 2003 | 151 | 0.400 |
Why?
|
| Humans | 76 | 2023 | 86601 | 0.400 |
Why?
|
| Electrodes | 8 | 2023 | 78 | 0.390 |
Why?
|
| Auditory Perception | 4 | 2022 | 96 | 0.380 |
Why?
|
| Child | 18 | 2020 | 6926 | 0.380 |
Why?
|
| Adolescent | 19 | 2020 | 8979 | 0.360 |
Why?
|
| Speech | 2 | 2021 | 84 | 0.360 |
Why?
|
| Hippocampus | 4 | 2022 | 442 | 0.350 |
Why?
|
| Scalp | 6 | 2022 | 72 | 0.340 |
Why?
|
| Frontal Lobe | 2 | 2008 | 130 | 0.340 |
Why?
|
| Subdural Space | 2 | 2007 | 9 | 0.320 |
Why?
|
| Seizures | 5 | 2018 | 295 | 0.320 |
Why?
|
| Male | 44 | 2020 | 40956 | 0.320 |
Why?
|
| Adult | 34 | 2020 | 25640 | 0.320 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2018 | 42 | 0.310 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2007 | 332 | 0.310 |
Why?
|
| Models, Animal | 3 | 2020 | 263 | 0.290 |
Why?
|
| Female | 43 | 2020 | 44507 | 0.290 |
Why?
|
| Vision Disorders | 3 | 2021 | 75 | 0.290 |
Why?
|
| Signal Processing, Computer-Assisted | 5 | 2010 | 201 | 0.260 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2019 | 37 | 0.260 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2007 | 579 | 0.250 |
Why?
|
| Implants, Experimental | 1 | 2003 | 16 | 0.240 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2003 | 6 | 0.240 |
Why?
|
| Prosopagnosia | 1 | 2003 | 1 | 0.230 |
Why?
|
| Dominance, Cerebral | 2 | 2000 | 66 | 0.230 |
Why?
|
| Imagination | 1 | 2003 | 41 | 0.230 |
Why?
|
| Blindness | 1 | 2003 | 41 | 0.230 |
Why?
|
| Middle Aged | 22 | 2020 | 25017 | 0.230 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 3 | 1998 | 17 | 0.230 |
Why?
|
| Young Adult | 7 | 2020 | 5974 | 0.220 |
Why?
|
| Sleep | 4 | 2022 | 444 | 0.220 |
Why?
|
| Spinal Cord Injuries | 1 | 2023 | 54 | 0.220 |
Why?
|
| Memory Consolidation | 1 | 2022 | 14 | 0.220 |
Why?
|
| Monitoring, Intraoperative | 1 | 2003 | 109 | 0.220 |
Why?
|
| Face | 1 | 2003 | 114 | 0.210 |
Why?
|
| Parietal Lobe | 1 | 2003 | 117 | 0.210 |
Why?
|
| Space Perception | 1 | 2003 | 115 | 0.210 |
Why?
|
| Equipment Design | 2 | 2016 | 406 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2600 | 0.200 |
Why?
|
| Somatosensory Cortex | 3 | 2000 | 129 | 0.200 |
Why?
|
| Health Personnel | 1 | 2003 | 202 | 0.200 |
Why?
|
| Reflex, Righting | 1 | 2020 | 2 | 0.200 |
Why?
|
| Deep Brain Stimulation | 2 | 2015 | 54 | 0.190 |
Why?
|
| Brain Damage, Chronic | 1 | 2000 | 26 | 0.190 |
Why?
|
| Theta Rhythm | 1 | 2020 | 27 | 0.190 |
Why?
|
| Models, Neurological | 7 | 2010 | 405 | 0.190 |
Why?
|
| Motor Activity | 3 | 2016 | 327 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2016 | 1204 | 0.190 |
Why?
|
| Nerve Regeneration | 1 | 2000 | 32 | 0.180 |
Why?
|
| Electrophysiology | 5 | 2012 | 401 | 0.180 |
Why?
|
| Isoflurane | 1 | 2020 | 64 | 0.180 |
Why?
|
| Posture | 2 | 2017 | 125 | 0.180 |
Why?
|
| Movement | 2 | 2023 | 299 | 0.180 |
Why?
|
| Acoustic Stimulation | 5 | 2022 | 130 | 0.180 |
Why?
|
| Anesthetics, Inhalation | 1 | 2020 | 95 | 0.180 |
Why?
|
| Algorithms | 7 | 2010 | 1830 | 0.180 |
Why?
|
| Caffeine | 1 | 2020 | 81 | 0.180 |
Why?
|
| Time Factors | 9 | 2019 | 5209 | 0.180 |
Why?
|
| Motor Cortex | 3 | 2016 | 195 | 0.180 |
Why?
|
| Entropy | 2 | 2010 | 38 | 0.170 |
Why?
|
| Hand | 1 | 2000 | 130 | 0.170 |
Why?
|
| Brain Waves | 1 | 2019 | 32 | 0.170 |
Why?
|
| Visual Acuity | 7 | 1997 | 194 | 0.170 |
Why?
|
| Implantable Neurostimulators | 1 | 2018 | 12 | 0.170 |
Why?
|
| Functional Laterality | 8 | 2019 | 201 | 0.170 |
Why?
|
| Evoked Potentials | 10 | 2003 | 190 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 132 | 0.160 |
Why?
|
| Limbic Encephalitis | 1 | 2018 | 11 | 0.160 |
Why?
|
| Glutamate Decarboxylase | 1 | 2018 | 32 | 0.160 |
Why?
|
| Sclerosis | 1 | 2017 | 28 | 0.160 |
Why?
|
| Neuronal Plasticity | 1 | 2000 | 187 | 0.160 |
Why?
|
| Sensation | 1 | 1998 | 45 | 0.150 |
Why?
|
| Encephalitis | 1 | 2018 | 104 | 0.150 |
Why?
|
| Stereotaxic Techniques | 1 | 2017 | 69 | 0.150 |
Why?
|
| Death, Sudden | 1 | 2017 | 40 | 0.150 |
Why?
|
| Microelectrodes | 3 | 2023 | 81 | 0.150 |
Why?
|
| Otolithic Membrane | 1 | 1997 | 12 | 0.150 |
Why?
|
| Prone Position | 1 | 2017 | 56 | 0.150 |
Why?
|
| Saccule and Utricle | 1 | 1997 | 19 | 0.150 |
Why?
|
| Computer Simulation | 6 | 2010 | 1078 | 0.150 |
Why?
|
| Cats | 1 | 1997 | 303 | 0.140 |
Why?
|
| Brain Diseases | 1 | 1998 | 180 | 0.140 |
Why?
|
| Wireless Technology | 1 | 2016 | 16 | 0.140 |
Why?
|
| Laser Therapy | 1 | 2017 | 142 | 0.140 |
Why?
|
| Antibodies | 1 | 2018 | 350 | 0.140 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2015 | 19 | 0.130 |
Why?
|
| Subthalamic Nucleus | 1 | 2015 | 22 | 0.130 |
Why?
|
| Parkinson Disease | 1 | 2015 | 132 | 0.120 |
Why?
|
| Video Recording | 2 | 2020 | 190 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 449 | 0.120 |
Why?
|
| Multiple Sclerosis | 2 | 1996 | 262 | 0.120 |
Why?
|
| Hypogastric Plexus | 1 | 2012 | 4 | 0.110 |
Why?
|
| Memory | 3 | 2004 | 225 | 0.110 |
Why?
|
| Urinary Retention | 1 | 2012 | 40 | 0.110 |
Why?
|
| Replantation | 1 | 2012 | 36 | 0.110 |
Why?
|
| Software | 2 | 2007 | 654 | 0.110 |
Why?
|
| Ureter | 1 | 2012 | 92 | 0.100 |
Why?
|
| Visual Pathways | 2 | 2003 | 152 | 0.100 |
Why?
|
| Neurons | 1 | 1999 | 1546 | 0.100 |
Why?
|
| Reaction Time | 7 | 1992 | 309 | 0.100 |
Why?
|
| Macaca | 2 | 2016 | 87 | 0.090 |
Why?
|
| Quadriplegia | 1 | 1989 | 22 | 0.090 |
Why?
|
| Photic Stimulation | 4 | 2019 | 493 | 0.090 |
Why?
|
| Skull | 3 | 2010 | 249 | 0.090 |
Why?
|
| Robotics | 1 | 2012 | 267 | 0.090 |
Why?
|
| Orientation | 2 | 1980 | 119 | 0.090 |
Why?
|
| Brain Stem | 1 | 1989 | 165 | 0.080 |
Why?
|
| Language Tests | 1 | 2008 | 37 | 0.080 |
Why?
|
| Wakefulness | 2 | 2020 | 134 | 0.080 |
Why?
|
| Animals | 9 | 2023 | 26581 | 0.080 |
Why?
|
| Anesthesia, General | 2 | 2020 | 114 | 0.080 |
Why?
|
| Oscillometry | 1 | 2007 | 25 | 0.080 |
Why?
|
| Visual Fields | 4 | 2004 | 98 | 0.080 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 118 | 0.070 |
Why?
|
| Electromyography | 2 | 2017 | 183 | 0.070 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2006 | 5 | 0.070 |
Why?
|
| Holography | 1 | 2006 | 4 | 0.070 |
Why?
|
| Cell Physiological Phenomena | 1 | 2006 | 24 | 0.070 |
Why?
|
| ROC Curve | 1 | 2008 | 752 | 0.070 |
Why?
|
| Vision Tests | 2 | 1983 | 20 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2012 | 754 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 1990 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2018 | 7988 | 0.060 |
Why?
|
| Age Factors | 5 | 1998 | 1849 | 0.060 |
Why?
|
| Communication | 1 | 2008 | 440 | 0.060 |
Why?
|
| Brain Neoplasms | 3 | 1999 | 763 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2012 | 3611 | 0.060 |
Why?
|
| Epilepsy, Absence | 1 | 2003 | 8 | 0.060 |
Why?
|
| Credentialing | 1 | 2003 | 13 | 0.060 |
Why?
|
| Ocular Hypertension | 1 | 1983 | 7 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 103 | 0.060 |
Why?
|
| Aged | 9 | 2017 | 18402 | 0.060 |
Why?
|
| Size Perception | 2 | 1980 | 6 | 0.060 |
Why?
|
| Eye Diseases | 1 | 1983 | 53 | 0.060 |
Why?
|
| Hemiplegia | 2 | 2000 | 15 | 0.060 |
Why?
|
| Glaucoma | 1 | 1983 | 30 | 0.050 |
Why?
|
| Models, Biological | 2 | 2006 | 1749 | 0.050 |
Why?
|
| Spatial Memory | 1 | 2022 | 27 | 0.050 |
Why?
|
| Spine | 1 | 2023 | 102 | 0.050 |
Why?
|
| Sound | 1 | 2022 | 26 | 0.050 |
Why?
|
| Patient Care | 1 | 2003 | 100 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2023 | 249 | 0.050 |
Why?
|
| Swine | 1 | 2023 | 555 | 0.050 |
Why?
|
| Infant | 4 | 2000 | 3045 | 0.050 |
Why?
|
| Neuropsychological Tests | 3 | 2017 | 502 | 0.050 |
Why?
|
| Mental Recall | 1 | 2022 | 159 | 0.050 |
Why?
|
| Respiratory Rate | 1 | 2020 | 20 | 0.050 |
Why?
|
| Anesthesia Recovery Period | 1 | 2020 | 56 | 0.050 |
Why?
|
| Hypoglycemia | 2 | 1992 | 107 | 0.050 |
Why?
|
| Neurologic Examination | 1 | 2000 | 118 | 0.050 |
Why?
|
| Afferent Pathways | 1 | 2000 | 77 | 0.040 |
Why?
|
| Aphasia | 1 | 1999 | 14 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 399 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2012 | 751 | 0.040 |
Why?
|
| Heart Rate | 2 | 2020 | 492 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 2705 | 0.040 |
Why?
|
| Hearing Disorders | 1 | 1998 | 7 | 0.040 |
Why?
|
| Auditory Threshold | 1 | 1998 | 17 | 0.040 |
Why?
|
| Carboxy-Lyases | 1 | 2018 | 22 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 1998 | 171 | 0.040 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1977 | 11 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 66 | 0.040 |
Why?
|
| Nonlinear Dynamics | 2 | 2010 | 73 | 0.040 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 110 | 0.040 |
Why?
|
| Videotape Recording | 1 | 1997 | 47 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2000 | 2378 | 0.040 |
Why?
|
| Hallucinations | 1 | 1996 | 27 | 0.040 |
Why?
|
| Gestational Age | 1 | 1997 | 311 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2018 | 267 | 0.040 |
Why?
|
| Arm | 1 | 2017 | 91 | 0.040 |
Why?
|
| Personality | 1 | 2018 | 133 | 0.040 |
Why?
|
| Interferon-beta | 1 | 1996 | 125 | 0.030 |
Why?
|
| Levodopa | 1 | 2015 | 36 | 0.030 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 182 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2006 | 3241 | 0.030 |
Why?
|
| Biomarkers | 2 | 2018 | 1718 | 0.030 |
Why?
|
| Dementia | 1 | 1996 | 187 | 0.030 |
Why?
|
| Mathematics | 2 | 1991 | 190 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3990 | 0.030 |
Why?
|
| Reference Values | 4 | 1994 | 674 | 0.030 |
Why?
|
| Aging | 1 | 1998 | 691 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2000 | 3636 | 0.030 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2012 | 28 | 0.030 |
Why?
|
| Brain Injuries | 1 | 1994 | 161 | 0.030 |
Why?
|
| Optic Neuritis | 1 | 1991 | 10 | 0.030 |
Why?
|
| Methods | 1 | 1991 | 152 | 0.030 |
Why?
|
| United States | 1 | 2003 | 6665 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2012 | 246 | 0.020 |
Why?
|
| Dura Mater | 1 | 2010 | 44 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2010 | 91 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 839 | 0.020 |
Why?
|
| Median Nerve | 1 | 1989 | 11 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1991 | 457 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 8475 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2010 | 303 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2003 | 596 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 369 | 0.020 |
Why?
|
| Electric Conductivity | 2 | 2005 | 144 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 4210 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 1673 | 0.020 |
Why?
|
| Insulin | 2 | 1992 | 1160 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 1990 | 236 | 0.020 |
Why?
|
| Cognition | 1 | 1992 | 570 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 5416 | 0.020 |
Why?
|
| Sugar Alcohol Dehydrogenases | 1 | 1986 | 2 | 0.020 |
Why?
|
| Imidazolidines | 1 | 1986 | 5 | 0.020 |
Why?
|
| Aldehyde Reductase | 1 | 1986 | 9 | 0.020 |
Why?
|
| Endarterectomy | 1 | 1986 | 20 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1992 | 567 | 0.020 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 1986 | 19 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 1986 | 40 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 1986 | 97 | 0.020 |
Why?
|
| Malingering | 1 | 1985 | 3 | 0.020 |
Why?
|
| Imidazoles | 1 | 1986 | 162 | 0.020 |
Why?
|
| Saccades | 1 | 2004 | 69 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2004 | 165 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2003 | 74 | 0.010 |
Why?
|
| Amblyopia | 1 | 1983 | 7 | 0.010 |
Why?
|
| Strabismus | 1 | 1983 | 10 | 0.010 |
Why?
|
| Depth Perception | 1 | 1983 | 19 | 0.010 |
Why?
|
| Pupil | 1 | 1983 | 18 | 0.010 |
Why?
|
| Optic Disk | 1 | 1983 | 13 | 0.010 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1983 | 17 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 307 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1986 | 1169 | 0.010 |
Why?
|
| Child Behavior | 1 | 1983 | 48 | 0.010 |
Why?
|
| Intraoperative Period | 2 | 1997 | 90 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2207 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2004 | 459 | 0.010 |
Why?
|
| Glucose Clamp Technique | 2 | 1992 | 39 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2004 | 373 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 2767 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1565 | 0.010 |
Why?
|
| Vision, Binocular | 1 | 1997 | 20 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1977 | 71 | 0.010 |
Why?
|
| Blood Glucose | 2 | 1992 | 873 | 0.010 |
Why?
|
| Child Development | 1 | 1997 | 163 | 0.010 |
Why?
|
| Form Perception | 1 | 1976 | 36 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 446 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1997 | 290 | 0.010 |
Why?
|
| Age of Onset | 1 | 1994 | 310 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1994 | 143 | 0.010 |
Why?
|
| Epinephrine | 1 | 1992 | 84 | 0.010 |
Why?
|
| Glucagon | 1 | 1992 | 111 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1992 | 97 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1996 | 1804 | 0.010 |
Why?
|
| Self Care | 1 | 1992 | 164 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1992 | 298 | 0.010 |
Why?
|
| Peroneal Nerve | 1 | 1986 | 9 | 0.000 |
Why?
|
| Neural Conduction | 1 | 1986 | 69 | 0.000 |
Why?
|
| Carotid Artery, Internal | 1 | 1986 | 69 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 6501 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 332 | 0.000 |
Why?
|
| Respiration | 1 | 1986 | 262 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1986 | 1823 | 0.000 |
Why?
|
| Neural Inhibition | 1 | 1977 | 97 | 0.000 |
Why?
|
| Light | 1 | 1977 | 289 | 0.000 |
Why?
|